News

Serametrix has partnered with the Ludwig Institute for Cancer Research (LICR). The agreement will combine LICR’s discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix.

BioTech Medics has received an independent clinical testing results for its Shban Hand Sanitizer Solution to prove Shban kills the H1N1 (Swine) Influenza A virus. Reportedly, an ATS

Basilea Pharmaceutica (Basilea) has reported that Toctino (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been

Johnson & Johnson has posted sales of $15.1b for the third quarter of 2009, a decrease of 5.3% compared to the third quarter of 2008. The net earnings

Sanofi Pasteur has reported the interim analysis of data from clinical trials of the US licensed Influenza A (H1N1) 2009 Monovalent Vaccine in infants and children 6 months

The European Commission has granted marketing authorisation to Boehringer Ingelheim for Mirapexin/Sifrol (pramipexole), once daily tablet in all EU/EEA countries. The drug is intended for the treatment of

Pfizer has reported that the US Federal Trade Commission (US FTC) has terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect

Fero Industries has entered into an agreement to acquire Pyro Pharmaceuticals of Irvine, California. Pyro develops therapeutics against multi-drug resistant infectious microorganisms. Pyro’s focus is on diseases in

Ortho Clinical Diagnostics (Ortho) has received FDA approval for Anti-HIV 1+2. Its a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 (Anti-HIV